Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy

✍ Scribed by Ahmad Awada; Martine J. Piccart; Suzanne F. Jones; Ronald A. Peck; Thierry Gil; David Lebwohl; Chi-Yuan Wu; Howard A. Burris

• Publisher: Springer
• Year: 2008
• Tongue: English
• Weight: 358 KB
• Volume: 63
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-008-0751-5